News Hub | News Direct

Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
Article thumbnail News Release

Synairgen CEO lays out plans for 2023 and beyond

Synairgen PLC

Synairgen PLC (AIM:SNG, OTC:SYGGF) chief executive Richard Marsden talks to Proactive following the release of full year results for calendar year 2022 - a year he says was "quite challenging at times." Marsden discusses the UK-based respiratory company's clinical development plan to take the SNG001 drug through Phase 3 trials and registration. The drug is being developed to help patients with respiratory viruses such as influenza virus, RSV, and SARS- CoV-2. The plan was formulated after a year of data collection and consultation with experts. He also highlights the company's relatively strong cash position, which he says will "allow [Synairgen] to get on with" its planned work schedule. Contact Details Proactive UK Ltd Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 28, 2023 03:00 AM Eastern Daylight Time

Video
Article thumbnail News Release

C4X Discovery Holdings making "slight pivot" to anti-inflammatory treatments

C4X Discovery Holdings PLC

C4X Discovery Holdings PLC (AIM:C4XD) CEO Clive Dix speaks to Thomas Warner from Proactive after releasing half-year results for the six months ending 31 January 2023. Dix gives his highlights from the interim results before turning his focus to what he describes as a "slight pivot" to anti-inflammatory treatments. C4X has a portfolio of anti-inflammatory targets, including a molecule for COPD, and four or five new anti-inflammatory targets in the pipeline, which will be revealed in due course. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 28, 2023 03:00 AM Eastern Daylight Time

Video
Article thumbnail News Release

Creo Medical Group FY22 results and recent funding - Proactive Research Analyst

Creo Medical Group PLC

Proactive Research Analyst John Savin gives the highlights from his latest research note on UK-based medical device company Creo Medical Group PLC (AIM:CREO). Savin talks about the company's recent performance and key products, before moving on to look at how it is positioned for the future. He also touches on a recent placing that generated a net £32 million. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 28, 2023 03:00 AM Eastern Daylight Time

Video
Article thumbnail News Release

ImmuPharma "looking forward" to upcoming FDA meetings

ImmuPharma PLC

ImmuPharma PLC (AIM:IMM, OTC:IMMPF) chief executive Tim McCarthy spoke to Thomas Warner at Proactive's London studio, following what he calls a "very busy time" for the specialty biopharmaceutical company. He discusses the latest developments and next steps for the P140 platform, highlighting the importance of two upcoming meetings with the US FDA. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 28, 2023 03:00 AM Eastern Daylight Time

Video
Article thumbnail News Release

Maureen McBride Named CEO of UNOS

United Network for Organ Sharing

Maureen McBride, Ph.D., has been named CEO of United Network for Organ Sharing (UNOS), the mission-driven, non-profit organization that serves as the nation’s organ donation and transplant system — the Organ Procurement and Transplantation Network (OPTN) — under contract with the federal government. “We conducted an exhaustive nationwide search for a new CEO and were pleased to find that the most qualified candidate is Dr. McBride,” said UNOS Board President Jerry McCauley, M.D., who chaired the Search Committee. “She impressed the Committee with her innovative spirit, clear-eyed vision of transformational change at UNOS and knowledge of the challenges facing the organ donation and transplantation community today. Since taking over as Interim CEO seven months ago, Dr. McBride has shown that she embodies a much-needed change in approach and operations at UNOS. She has put the organization on a new trajectory by increasing transparency and communication with the organ donation and transplantation community, regulators, Congress and the public, and advancing new initiatives to modernize and improve the organ donation and transplant system to benefit patients and ensure public trust.” Under McBride’s leadership, UNOS released an Action Agenda earlier this year, a comprehensive set of improvements in critical areas of the transplant system, including transparency, accountability, equity, transportation and modernization. McBride has worked for UNOS since 1995. She has served as Interim CEO since October 2022 and before that, as Chief Operating Officer managing the OPTN contract. She was also the organization’s Director of Research from 2006 to 2014 and contributed to more than 50 research manuscripts and publications. As CEO, she directs the efforts of 450 UNOS staff to ensure that the nation’s organ donation and transplant network efficiently and fairly serves the needs of transplant candidates and recipients, living donors and donor family members, and professionals in the field. She will be the first woman to lead the organization. “I am humbled, thrilled and energized to be selected to serve as CEO of UNOS,” McBride said. “As long as there are patients in desperate need of organs, we have more work ahead of us. As we move forward in our mission to save more lives, I look forward to leading UNOS during a time of immense change. As I said in my first official remarks as Interim CEO: we can do better, we must do better, and we will do better. We are excited to show our ongoing commitment to saving lives, how we are best situated to help usher in proposed improvements and how our expertise should remain an integral part of the system. Additionally, I am excited to continue working with UNOS’ other non-OPTN business lines to enhance and grow our organization.” In selecting McBride, the UNOS Corporate Affairs Committee agreed this is a pivotal moment in the organization’s history. They cited her leadership skills and proven ability to navigate organizational change both internally and externally as the lifesaving work continues and as UNOS prepares to respond to the federal government’s upcoming RFPs for the new OPTN contract. This includes her institutional knowledge of UNOS and the entire organ donation and transplant community; her experience in the field; her commitment to clear and frequent communication to build trust, understanding and consensus; and her unquestioned commitment to the organization and its mission to save as many lives as possible through organ donation and transplantation. She received her bachelor of science in mathematics from Loyola College in Maryland and her Ph.D. in biostatistics from Virginia Commonwealth University, Medical College of Virginia. McBride has served as the Executive Director of the OPTN since October 2022. She will begin her new role with UNOS immediately. About UNOS United Network for Organ Sharing (UNOS) is the mission-driven non-profit serving as the nation’s transplant system under contract with the federal government. We lead the network of transplant hospitals, organ procurement organizations, and thousands of volunteers who are dedicated to honoring the gifts of life entrusted to us and to making lifesaving transplants possible for patients in need. Working together, we leverage data and advances in science and technology to continuously strengthen the system, increase the number of organs recovered and the number of transplants performed, and ensure patients across the nation have equitable access to transplant. Contact Details United Network for Organ Sharing Anne Paschke +1 804-782-4730 anne.paschke@unos.org Company Website https://unos.org

April 27, 2023 02:36 PM Eastern Daylight Time

Image
Article thumbnail News Release

NuGen Medical Devices begins feasibility study in the Netherlands for InsuJet and Ozempic

NuGen Medical Devices

NuGen Medical Devices executive chairman Tony Di Benedetto joined Steve Darling from Proactive to provide details about the company that is developing the next generation of needle-free technologies for both humans and animals. Di Benedetto shares with Proactive more about the technology behind products InsuJet and PetJet and also about an assessment and feasibility study in the Netherlands of InsuJet for Semaglutide or its more widely known name Ozempic. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

April 27, 2023 01:36 PM Eastern Daylight Time

Video
Article thumbnail News Release

Planet Based Foods creating clean food using hemp as key sustainable ingredient

Planet Based Foods

Planet Based Foods CEO Braelyn Davis joined Steve Darling from Proactive to share news about the company which creates unique products using a clean blend of hemp seed, pea protein and brown rice, to maximize nutrients and fiber with zero waste. Davis tells Proactive more about the company, its product line and which sectors it will look to grow in. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

April 27, 2023 01:12 PM Eastern Daylight Time

Video
Article thumbnail News Release

USDA’s ‘Defend the Flock’ Campaign Addresses How to Help Keep Your Backyard Chickens Safe from Bird Flu

YourUpdateTV

Over the last several years, more people have turned to raising chickens at home. But a highly infectious bird flu called Highly Pathogenic Avian Influenza (HPAI) has created challenges for backyard growers, already affecting more than 58 million birds nationwide. Recently, Dr. Julie Gauthier, the Assistant Director of Poultry Health at the U.S. Department of Agriculture, participated in a nationwide satellite media tour to discuss the crisis and how their ‘Defend the Flock’ campaign is helping address the issue. A video accompanying this announcement is available at: https://youtu.be/-7Wg4IcF5Bc The U.S. poultry industry is one of the largest in the world and an important sector of our agricultural economy. Disease outbreaks can devastate flocks, impact trade, cause job and financial losses, and affect prices on eggs, prepared poultry, and other staples. The Defend the Flock education program offers free tools and resources to help everyone who handles or works with poultry follow proper biosecurity practices. These practices will help keep your birds healthy and reduce the risk of avian influenza and other infectious diseases. Tips include: · Keep flocks away from open water and wild birds that can carry disease · Separating your poultry from the rest of your property, using only one entry and exit point · Clean regularly and wear dedicated clothes and shoes when tending to your flock · Clean equipment and vehicles with soap and water before and after they are near your flock · Don’t share tools, poultry supplies or equipment with other flock owners · Report sick birds and know the warning signs, including lower egg production, soft-shelled or misshapen eggs, and runny nose, sneezing and trouble breathing. Report any signs of illness or unexplained deaths to your veterinarian, animal health official, or call the USDA at 866-536-7593 For more tips and advice to keep your chickens safe, search online for ‘Defend the Flock’ About Dr. Julie Gauthier Dr. Julie Gauthier is Assistant Director for Poultry Health and a Veterinary Medical Officer at the U.S. Department of Agriculture/APHIS. The doctor is a Veterinary Medicine Prevention Officer for the U.S. Army Reserve where she has served for more than five years. Dr. Gauthier received her Master’s in Public Health from the Yale School of Public Health and her Doctorate in Veterinary Medicine from Michigan State University. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

April 27, 2023 10:31 AM Eastern Daylight Time

Video
Article thumbnail News Release

Pangea Natural Foods seeing success with the manufacturing and distribution of healthy food

Pangea Natural Foods

Pangea Natural Foods CEO Pratap Sandhu joined Steve Darling from Proactive to talk more about the company which has several verticals in the healthy food sector. Sandhu tells Proactive more about the products the company offers including food manufacturing, co-packing services and food distribution. He also discusses its growth plans. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

April 26, 2023 01:31 PM Eastern Daylight Time

Video
1 ... 128129130131132 ... 302